Feedback / Questions
UX-DA001 - Shanghai Yuesai Biotech
https://www.manilatimes.net/2025/05/23/tmt-newswire/pr-newswire/unixell-biotechnology-announces-the-first-patient-dosed-with-ux-da001-an-investigational-autologous-ipsc-based-cell-therapy-for-the-treatment-of-parkinsons-disease-in-its-phase-1-study/2119999
 
May 23, 2025
 
SHARE THIS
  • Print
  • Email
  • More sharing
    Reddit
    StumbleUpon
    Delicious